Verrica Pharmaceuticals Inc (NASDAQ:VRCA)
| 4.75 Delayed Data As of Jan 26 |  +0.09 / +1.93%Today’s Change | 1.77 Today|||52-Week Range 9.22 | +72.73% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Assets | Cash | 38.3M | 10.3M | 24.4M | 19.9M | |
| Short Term Investment Cash | -64.8M | -28.0M | 14.2M | -4.6M | ||
| Cash & Short Term Investments | 97.0M | 89.8M | 83.3M | 78.8M | ||
| Receivables | Receivables | 0.00 | 0.00 | 6.0K | 0.00 | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Other Current Assets | 1.7M | 1.3M | 1.4M | 985.0K | |
| Current Assets | 98.7M | 91.2M | 84.7M | 79.7M | ||
| Total Assets | Property, Plant and Equipment - Gross | -- | 275.0K | 1.3M | 1.5M | |
| Depreciation | -- | -20.0K | -31.0K | -42.0K | ||
| Other Assets | 14.0K | 499.0K | 14.0K | 14.0K | ||
| Total Assets | 98.8M | 91.9M | 86.0M | 81.3M | ||
| Liabilities | Accounts Payable | 1.1M | 960.0K | 1.1M | 1.5M | |
| Short Term Debt | 0.00 | 0.00 | 122.0K | 124.0K | ||
| Accrued Expenses | 1.3M | 256.0K | 1.4M | 1.8M | ||
| Other Current Liabilities | 1.3M | 256.0K | 1.4M | 1.8M | ||
| Other Liabilities | 2.5M | 2.5M | 3.1M | 4.3M | ||
| Total Liabilities | Long Term Debt | 0.00 | 0.00 | 156.0K | 124.0K | |
| Total Liabilities | 2.5M | 2.5M | 3.2M | 4.4M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 96.4M | 89.4M | 82.8M | 76.8M | ||
| Total Shareholder Equity | 96.4M | 89.4M | 82.8M | 76.8M | ||
| Share Information | Common Shares Outstanding | 25.7M | 25.7M | 25.7M | 25.7M | |
| Addtl. Info. | No data currently available for this section. | |||||
